{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:54:54Z","timestamp":1792173294591,"version":"4.4.0"},"reference-count":271,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY10101"],"award-info":[{"award-number":["EY10101"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY018594"],"award-info":[{"award-number":["R01EY018594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY023691"],"award-info":[{"award-number":["EY023691"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY021886"],"award-info":[{"award-number":["EY021886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["I01 BX002386"],"award-info":[{"award-number":["I01 BX002386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY01792"],"award-info":[{"award-number":["EY01792"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000050"],"award-info":[{"award-number":["UL1TR000050"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.bbagen.2015.09.007","type":"journal-article","created":{"date-parts":[[2015,9,13]],"date-time":"2015-09-13T02:04:18Z","timestamp":1442109858000},"page":"2422-2438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"title":["Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications"],"prefix":"10.1016","volume":"1850","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1061-0561","authenticated-orcid":false,"given":"Amit","family":"Walia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica F.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6406-305X","authenticated-orcid":false,"given":"Yu-hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"Rosenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri T.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2015.09.007_bb0005","first-page":"412","article-title":"Angiogenesis","volume":"vol. 27","author":"Folkman","year":"1984"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0010","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/febs.13234","article-title":"Simultaneous in vivo imaging of blood and lymphatic vessel growth in Prox1-GFP\/Flk1::myr-mCherry mice","volume":"282","author":"Zhu","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","article-title":"Novel aspects of corneal angiogenic and lymphangiogenic privilege","volume":"29","author":"Ellenberg","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0030","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.yexcr.2005.11.015","article-title":"Antiangiogenesis in cancer therapy\u2014endostatin and its mechanisms of action","volume":"312","author":"Folkman","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0035","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1200\/JCO.2006.05.6762","article-title":"Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors","volume":"24","author":"Kulke","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0040","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.bbagen.2013.12.029","article-title":"Matrikines from basement membrane collagens: a new anti-cancer strategy","volume":"1840","author":"Monboisse","year":"2014","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0045","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2741\/3712","article-title":"Matricryptins derived from collagens and proteoglycans","volume":"16","author":"Ricard-Blum","year":"2011","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/exd.12435","article-title":"Matricryptins and matrikines: biologically active fragments of the extracellular matrix","volume":"23","author":"Ricard-Blum","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0055","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/jnci\/94.20.1520","article-title":"First clinical trials of endostatin yield lukewarm results","volume":"94","author":"Twombly","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0060","doi-asserted-by":"crossref","first-page":"a004978","DOI":"10.1101\/cshperspect.a004978","article-title":"The collagen family","volume":"3","author":"Ricard-Blum","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O'Reilly","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0070","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1006\/bbrc.1993.2288","article-title":"Identification of a novel collagen chain represented by extensive interruptions in the triple-helical region","volume":"196","author":"Abe","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/A:1024540701634","article-title":"Collagen type 1 retards tube formation by human microvascular endothelial cells in a fibrin matrix","volume":"5","author":"Kroon","year":"2002","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0080","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.2174\/138161207782794176","article-title":"Type I collagen and collagen mimetics as angiogenesis promoting superpolymers","volume":"13","author":"Twardowski","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0085","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/ijc.23147","article-title":"Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma","volume":"122","author":"van Kempen","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0090","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/bbrc.2001.5970","article-title":"NC1 domain of human type VIII collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis","volume":"289","author":"Xu","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0095","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/1535-7163.MCT-06-0207","article-title":"The NC1 domain of type XIX collagen inhibits in vivo melanoma growth","volume":"6","author":"Ramont","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1432-1033.1981.tb05690.x","article-title":"A network model for the organization of type IV collagen molecules in basement membranes","volume":"120","author":"Timpl","year":"1981","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0105","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0955-0674(96)80102-5","article-title":"Macromolecular organization of basement membranes","volume":"8","author":"Timpl","year":"1996","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0110","first-page":"1","article-title":"Structure, development, and molecular pathology of basement membranes","volume":"29","author":"Timpl","year":"1986","journal-title":"Int. Rev. Exp. Pathol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0115","doi-asserted-by":"crossref","first-page":"22339","DOI":"10.1074\/jbc.M000519200","article-title":"Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells","volume":"275","author":"Li","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0120","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.1073\/pnas.89.21.10144","article-title":"Identification of a previously unknown human collagen chain, alpha 1(XV), characterized by extensive interruptions in the triple-helical region","volume":"89","author":"Myers","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0125","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1073\/pnas.91.10.4229","article-title":"Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins","volume":"91","author":"Oh","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0130","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1016\/S0021-9258(17)37611-1","article-title":"Primary structure of the alpha 1 chain of human type XV collagen and exon-intron organization in the 3\u2032 region of the corresponding gene","volume":"269","author":"Kivirikko","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0135","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1016\/S0021-9258(17)41739-X","article-title":"The human alpha 1(XV) collagen chain contains a large amino-terminal non-triple helical domain with a tandem repeat structure and homology to alpha 1(XVIII) collagen","volume":"269","author":"Muragaki","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0140","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1006\/bbrc.1999.0248","article-title":"Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin","volume":"255","author":"Ramchandran","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbapap.2004.10.013","article-title":"Identification and characterization of novel endogenous proteolytic forms of the human angiogenesis inhibitors restin and endostatin","volume":"1747","author":"John","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0150","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1074\/jbc.270.9.4705","article-title":"Identification of three N-terminal ends of type XVIII collagen chains and tissue-specific differences in the expression of the corresponding transcripts. The longest form contains a novel motif homologous to rat and Drosophila frizzled proteins","volume":"270","author":"Rehn","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0155","doi-asserted-by":"crossref","first-page":"13929","DOI":"10.1016\/S0021-9258(17)36737-6","article-title":"Primary structure of the alpha 1 chain of mouse type XVIII collagen, partial structure of the corresponding gene, and comparison of the alpha 1(XVIII) chain with its homologue, the alpha 1(XV) collagen chain","volume":"269","author":"Rehn","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0160","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1093\/emboj\/17.15.4249","article-title":"Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin","volume":"17","author":"Sasaki","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0165","doi-asserted-by":"crossref","first-page":"8763","DOI":"10.1073\/pnas.92.19.8763","article-title":"Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones","volume":"92","author":"Muragaki","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0170","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0002-9440(10)65603-9","article-title":"The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans","volume":"153","author":"Saarela","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0945-053X(98)90003-8","article-title":"Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts","volume":"16","author":"Saarela","year":"1998","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.matbio.2010.11.001","article-title":"The multiple functions of collagen XVIII in development and disease","volume":"30","author":"Seppinen","year":"2011","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0185","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrm1702","article-title":"Basement membrane proteoglycans: from cellar to ceiling","volume":"6","author":"Iozzo","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0190","first-page":"2520","article-title":"Anti-angiogenic cues from vascular basement membrane collagen","volume":"60","author":"Colorado","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0195","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/j.yexcr.2008.08.011","article-title":"Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor","volume":"314","author":"Nyberg","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0200","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1074\/jbc.275.2.1209","article-title":"Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth","volume":"275","author":"Kamphaus","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0205","doi-asserted-by":"crossref","first-page":"37632","DOI":"10.1074\/jbc.M307339200","article-title":"Canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells","volume":"278","author":"Panka","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0210","doi-asserted-by":"crossref","first-page":"23745","DOI":"10.1074\/jbc.C000186200","article-title":"Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties","volume":"275","author":"Maeshima","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-1536-3-13","article-title":"Angiogenesis and chronic kidney disease","volume":"3","author":"Maeshima","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0220","series-title":"Protein Identification and Analysis Tools on the ExPASy Server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0225","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1242\/dev.01037","article-title":"Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development","volume":"131","author":"Poschl","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0230","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1083\/jcb.130.5.1219","article-title":"Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies","volume":"130","author":"Ninomiya","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0235","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1101\/gad.10.23.2981","article-title":"Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome","volume":"10","author":"Cosgrove","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0240","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1535-6108(03)00133-8","article-title":"Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin","volume":"3","author":"Hamano","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0245","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1073\/pnas.98.3.1194","article-title":"Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice","volume":"98","author":"Eklund","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0250","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1113\/jphysiol.2013.263574","article-title":"Image-based assessment of microvascular function and structure in collagen XV- and XVIII-deficient mice","volume":"592","author":"Rygh","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0255","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0945-053X(01)00187-1","article-title":"Developmentally regulated expression of type XV collagen correlates with abnormalities in Col15a1\u2212\/\u2212 mice","volume":"21","author":"Muona","year":"2002","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0260","doi-asserted-by":"crossref","first-page":"14490","DOI":"10.1523\/JNEUROSCI.2644-10.2010","article-title":"Lack of collagen XV impairs peripheral nerve maturation and, when combined with laminin-411 deficiency, Leads to basement membrane abnormalities and sensorimotor dysfunction","volume":"30","author":"Rasi","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0265","first-page":"181","article-title":"Retinal detachment and encephalocele","volume":"8","author":"Knobloch","year":"1971","journal-title":"J. Pediatr. Ophthalmol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0270","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/hmg\/9.13.2051","article-title":"Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome)","volume":"9","author":"Sertie","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajmg.a.20070","article-title":"Evidence of neuronal migration disorders in Knobloch syndrome: clinical and molecular analysis of two novel families","volume":"119A","author":"Kliemann","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0280","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/hmg\/5.6.843","article-title":"A gene which causes severe ocular alterations and occipital encephalocele (Knobloch syndrome) is mapped to 21q22.3","volume":"5","author":"Sertie","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0285","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ajmg.1320420605","article-title":"The second report of Knobloch syndrome","volume":"42","author":"Czeizel","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0290","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ajmg.1320460221","article-title":"Congenital scalp defects and vitreoretinal degeneration: redefining the Knobloch syndrome","volume":"46","author":"Seaver","year":"1993","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0295","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ajmg.1320520209","article-title":"Knobloch syndrome in a large Brazilian consanguineous family: confirmation of autosomal recessive inheritance","volume":"52","author":"Passos-Bueno","year":"1994","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0300","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<286::AID-AJMG16>3.0.CO;2-B","article-title":"Report of two sibs with Knobloch syndrome (encephalocoele and viteroretinal degeneration) and other anomalies","volume":"78","author":"Wilson","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0305","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/(SICI)1096-8628(20000117)90:2<146::AID-AJMG11>3.0.CO;2-Z","article-title":"Knobloch syndrome involving midline scalp defect of the frontal region","volume":"90","author":"Sniderman","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0310","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1016\/j.febslet.2008.09.052","article-title":"Collagen XVIII and corneal reinnervation following keratectomy","volume":"582","author":"Sakimoto","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0315","first-page":"2517","article-title":"Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment","volume":"42","author":"Lin","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0320","doi-asserted-by":"crossref","first-page":"25404","DOI":"10.1074\/jbc.273.39.25404","article-title":"Collagen XVIII is a basement membrane heparan sulfate proteoglycan","volume":"273","author":"Halfter","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0325","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1387\/ijdb.041895ms","article-title":"Development and pathology of the hyaloid, choroidal and retinal vasculature","volume":"48","author":"Saint-Geniez","year":"2004","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0330","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/emboj\/21.7.1535","article-title":"Lack of collagen XVIII\/endostatin results in eye abnormalities","volume":"21","author":"Fukai","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0335","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1096\/fj.04-3101fje","article-title":"Abnormal maturation of the retinal vasculature in type XVIII collagen\/endostatin deficient mice and changes in retinal glial cells due to lack of collagen types XV and XVIII","volume":"19","author":"Hurskainen","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0340","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0345","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1167\/iovs.02-1180","article-title":"Age-dependent iris abnormalities in collagen XVIII\/endostatin deficient mice with similarities to human pigment dispersion syndrome","volume":"44","author":"Marneros","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0350","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1096\/fj.02-1001fje","article-title":"Lack of type XVIII collagen results in anterior ocular defects","volume":"17","author":"Ylikarppa","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0355","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.emboj.7600014","article-title":"Collagen XVIII\/endostatin is essential for vision and retinal pigment epithelial function","volume":"23","author":"Marneros","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013919","article-title":"Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans","volume":"5","author":"Bishop","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0365","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.1074\/jbc.M110.166132","article-title":"Lack of collagen XVIII long isoforms affects kidney podocytes, whereas the short form is needed in the proximal tubular basement membrane","volume":"286","author":"Kinnunen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0370","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0945-053X(03)00074-X","article-title":"Double knockout mice reveal a lack of major functional compensation between collagens XV and XVIII","volume":"22","author":"Ylikarppa","year":"2003","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0375","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s004290050289","article-title":"Regression of the hyaloid vessels and pupillary membrane of the mouse","volume":"200","author":"Ito","year":"1999","journal-title":"Anat. Embryol. (Berl.)"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0380","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-5793(00)02249-3","article-title":"Generation and degradation of human endostatin proteins by various proteinases","volume":"486","author":"Ferreras","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0385","first-page":"6052","article-title":"The generation of endostatin is mediated by elastase","volume":"59","author":"Wen","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0390","first-page":"1478","article-title":"Expression of cathepsin L in human tumors","volume":"51","author":"Chauhan","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112136","article-title":"Increased expression of cathepsin L: a novel independent prognostic marker of worse outcome in hepatocellular carcinoma patients","volume":"9","author":"Ruan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0400","first-page":"1","article-title":"Prognostic and predictive value of cathepsins D and L in operable breast cancer patients","volume":"52","author":"Jagodic","year":"2005","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0405","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ijc.24275","article-title":"Localization of nuclear cathepsin L and its association with disease progression and poor outcome in colorectal cancer","volume":"125","author":"Sullivan","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0410","first-page":"102","article-title":"Expression of cathepsin L in nasopharyngeal carcinoma and its clinical significance","volume":"31","author":"Xu","year":"2009","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0415","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S1368-8375(03)00034-4","article-title":"Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression","volume":"39","author":"Macabeo-Ong","year":"2003","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0420","first-page":"1109","article-title":"Cathepsin L is highly expressed in gastrointestinal stromal tumors","volume":"39","author":"Miyamoto","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0425","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1177\/147323001003800604","article-title":"Cathepsin L is associated with proliferation and clinical outcome of urothelial carcinoma of the bladder","volume":"38","author":"Yan","year":"2010","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0430","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00006676-200410000-00005","article-title":"Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma","volume":"29","author":"Niedergethmann","year":"2004","journal-title":"Pancreas"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0435","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0440","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0070-2153(03)54004-2","article-title":"Membrane type-matrix metalloproteinases (MT-MMP)","volume":"54","author":"Zucker","year":"2003","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0450","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/pro.5560040502","article-title":"The metzincins\u2013topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases","volume":"4","author":"Stocker","year":"1995","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0455","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/emboj\/19.6.1187","article-title":"Secreted cathepsin L generates endostatin from collagen XVIII","volume":"19","author":"Felbor","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0460","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1016\/j.febslet.2005.05.043","article-title":"Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen","volume":"579","author":"Chang","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0465","first-page":"20","article-title":"Immunolocalization and gene expression of matrilysin during corneal wound healing","volume":"40","author":"Lu","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0470","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1357-4310(00)01686-5","article-title":"Matrix metalloproteinases: multifunctional contributors to tumor progression","volume":"6","author":"McCawley","year":"2000","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0475","first-page":"420","article-title":"Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells","volume":"1","author":"Yang","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0480","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0092-8674(00)81235-0","article-title":"Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3","volume":"85","author":"Brooks","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0485","first-page":"5410","article-title":"Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase","volume":"60","author":"Kim","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0490","doi-asserted-by":"crossref","first-page":"22404","DOI":"10.1074\/jbc.M210325200","article-title":"Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13","volume":"278","author":"Nyberg","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0495","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0962-8924(03)00129-6","article-title":"Tales from the crypt[ic] sites of the extracellular matrix","volume":"13","author":"Schenk","year":"2003","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0500","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1158\/1078-0432.CCR-06-1520","article-title":"Vascular endothelial growth factor signaling pathways: therapeutic perspective","volume":"12","author":"Kowanetz","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0505","doi-asserted-by":"crossref","first-page":"26722","DOI":"10.1074\/jbc.273.41.26722","article-title":"Extracellular signal-regulated protein kinase\/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation","volume":"273","author":"Pedram","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0510","doi-asserted-by":"crossref","first-page":"27872","DOI":"10.1074\/jbc.M202771200","article-title":"Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR\/Flk-1","volume":"277","author":"Kim","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0515","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1016\/j.febslet.2014.09.034","article-title":"Involvement of lysosomal degradation in VEGF-C-induced down-regulation of VEGFR-3","volume":"588","author":"Han","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0520","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2174\/092986612802084465","article-title":"Characterization of the interaction between endostatin short peptide and VEGF receptor 3","volume":"19","author":"Han","year":"2012","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0525","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jcb.10675","article-title":"Integrin clipping: a novel adhesion switch?","volume":"91","author":"Demetriou","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0530","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.celrep.2012.07.001","article-title":"Target-derived matricryptins organize cerebellar synapse formation through alpha3beta1 integrins","volume":"2","author":"Su","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0535","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.0730882100","article-title":"Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins","volume":"100","author":"Sudhakar","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0540","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1073\/pnas.98.3.1024","article-title":"Interaction of endostatin with integrins implicated in angiogenesis","volume":"98","author":"Rehn","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0545","doi-asserted-by":"crossref","first-page":"22029","DOI":"10.1074\/jbc.M109.002840","article-title":"Molecular interplay between endostatin, integrins, and heparan sulfate","volume":"284","author":"Faye","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0550","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1073\/pnas.92.13.6161","article-title":"The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0555","first-page":"5580","article-title":"Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells","volume":"62","author":"Wickstrom","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0560","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajpath.2011.12.018","article-title":"Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase","volume":"180","author":"Morais","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0565","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(00)81604-9","article-title":"A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth","volume":"94","author":"Wary","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0570","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1097-2765(01)00225-8","article-title":"Cell surface glypicans are low-affinity endostatin receptors","volume":"7","author":"Karumanchi","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0575","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1093\/emboj\/18.22.6240","article-title":"Structural basis and potential role of heparin\/heparan sulfate binding to the angiogenesis inhibitor endostatin","volume":"18","author":"Sasaki","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0580","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2005.06.011","article-title":"Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans","volume":"333","author":"Reis","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0585","doi-asserted-by":"crossref","first-page":"22041","DOI":"10.1074\/jbc.M109.002964","article-title":"The first draft of the endostatin interaction network","volume":"284","author":"Faye","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0590","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1083\/jcb.130.3.503","article-title":"Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1","volume":"130","author":"Bornstein","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0595","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1097-2765(04)00102-9","article-title":"Endostatin's antiangiogenic signaling network","volume":"13","author":"Abdollahi","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0600","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1074\/jbc.M210445200","article-title":"Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan","volume":"278","author":"Mongiat","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0605","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/002215540305100303","article-title":"The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo","volume":"51","author":"Miosge","year":"2003","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0610","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrm1014","article-title":"Transglutaminases: crosslinking enzymes with pleiotropic functions","volume":"4","author":"Lorand","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0615","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/BJ20091594","article-title":"Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells","volume":"427","author":"Faye","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0620","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/bj2620633","article-title":"Bovine aortic endothelial cell transglutaminase. Enzyme characterization and regulation of activity","volume":"262","author":"Korner","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0625","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.yexcr.2006.05.019","article-title":"Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF","volume":"312","author":"Dardik","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0630","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2013.12.038","article-title":"Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimal matrix","volume":"233","author":"Neufeld","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0635","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1194\/jlr.M500241-JLR200","article-title":"Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis","volume":"46","author":"Zeng","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0640","doi-asserted-by":"crossref","first-page":"10621","DOI":"10.1523\/JNEUROSCI.22-24-10621.2002","article-title":"Aberrant neuronal and paracellular deposition of endostatin in brains of patients with Alzheimer's disease","volume":"22","author":"Deininger","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0645","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-5793(03)00218-7","article-title":"Recombinant endostatin forms amyloid fibrils that bind and are cytotoxic to murine neuroblastoma cells in vitro","volume":"539","author":"Kranenburg","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0650","doi-asserted-by":"crossref","first-page":"13748","DOI":"10.1021\/bi0011330","article-title":"Amyloid fibril formation by A beta 16\u201322, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR","volume":"39","author":"Balbach","year":"2000","journal-title":"Biochemistry"},{"issue":"Pt 6","key":"10.1016\/j.bbagen.2015.09.007_bb0655","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/jcs.112.6.761","article-title":"Structure and functions of nucleolin","volume":"112","author":"Ginisty","year":"1999","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0660","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1182\/blood-2005-07-2961","article-title":"The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin","volume":"107","author":"Huang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0665","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1083\/jcb.200304132","article-title":"Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels","volume":"163","author":"Christian","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0670","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood-2007-01-064428","article-title":"Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin","volume":"110","author":"Shi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0675","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1074\/jbc.M002016200","article-title":"Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants","volume":"276","author":"Gille","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0680","doi-asserted-by":"crossref","first-page":"11528","DOI":"10.1158\/0008-5472.CAN-07-1458","article-title":"Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice","volume":"67","author":"Brideau","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0685","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1096\/fasebj.13.14.1911","article-title":"Molecular dissection of nucleolin's role in growth and cell proliferation: new insights","volume":"13","author":"Srivastava","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0690","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1126\/science.295.5563.2198","article-title":"Cancer therapy. Setbacks for endostatin","volume":"295","author":"Marshall","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0695","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M412072200","article-title":"Contributions of disulfide bonds in a nested pattern to the structure, stability, and biological functions of endostatin","volume":"280","author":"Zhou","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0700","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1021\/bi0357863","article-title":"Acid-induced unfolding mechanism of recombinant human endostatin","volume":"43","author":"Li","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0705","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.2174\/092986709789712907","article-title":"The medicinal chemistry of peptides","volume":"16","author":"Nestor","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0710","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.0730882100","article-title":"Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by \u03b1v\u03b23 and \u03b15\u03b21 integrins","volume":"100","author":"Sudhakar","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0715","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003421","article-title":"A peptide derived from endostatin ameliorates organ fibrosis","volume":"4","author":"Yamaguchi","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0720","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1158\/0008-5472.CAN-04-1833","article-title":"27-Amino-Acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity","volume":"65","author":"Tjin Tham","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112448","article-title":"Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization","volume":"9","author":"Bai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0730","first-page":"191","article-title":"N-\/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent","volume":"11","author":"Cho","year":"2004","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0735","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1021\/bi100489x","article-title":"The N-terminal integrity is critical for the stability and biological functions of endostatin","volume":"49","author":"Fu","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0740","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.febslet.2007.05.058","article-title":"Contributions of Zn(II)-binding to the structural stability of endostatin","volume":"581","author":"Han","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0745","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1074\/jbc.M309868200","article-title":"Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations","volume":"279","author":"Ricard-Blum","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0750","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0014-4827(02)00057-5","article-title":"Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo","volume":"283","author":"Cattaneo","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0755","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.fertnstert.2005.07.1290","article-title":"Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model","volume":"85","author":"Becker","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0760","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.ki.5002040","article-title":"Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model","volume":"71","author":"Tanabe","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0765","doi-asserted-by":"crossref","first-page":"20178","DOI":"10.1074\/jbc.M312921200","article-title":"An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells","volume":"279","author":"Wickstr\u00f6m","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0770","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1039\/b604811k","article-title":"A molecular dynamics study of human endostatin and its synthetic fragments with antiangiogenic properties","volume":"8","author":"Pieraccini","year":"2006","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0775","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1021\/jm0308287","article-title":"Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities","volume":"46","author":"Chillemi","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0780","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2007.06.155","article-title":"Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR\/Flk-1 of endothelial cells","volume":"361","author":"Ling","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0785","unstructured":"Y. Luo, B. Zhou, Z. Zhang, N-Terminal Modified Recombinant Human Endostatin and its Production, in, Google Patents, 2004."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0790","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/37126","article-title":"Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance","volume":"390","author":"Boehm","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0795","first-page":"189","article-title":"Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate","volume":"19","author":"Chaplin","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0800","doi-asserted-by":"crossref","first-page":"11721","DOI":"10.1074\/jbc.274.17.11721","article-title":"Endostatin induces endothelial cell apoptosis","volume":"274","author":"Dhanabal","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0805","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/mvre.1994.1003","article-title":"Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane","volume":"47","author":"Nguyen","year":"1994","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0810","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1021507031486","article-title":"The sponge\/Matrigel angiogenesis assay","volume":"5","author":"Akhtar","year":"2002","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0815","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/bbrc.1999.1342","article-title":"Inhibitory effect of full-length human endostatin on in vitro angiogenesis","volume":"263","author":"Taddei","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0820","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.cgt.7700463","article-title":"Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo","volume":"9","author":"Shi","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0825","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.febslet.2008.06.014","article-title":"Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis","volume":"582","author":"Kojima","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0830","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1158\/1535-7163.MCT-14-0836","article-title":"Endostatin has ATPase activity, which mediates its antiangiogenic and antitumor activities","volume":"14","author":"Wang","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0835","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3677","article-title":"Lymphangiogenesis and lymphatic vessel remodelling in cancer","volume":"14","author":"Stacker","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0840","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/j.1460-2075.1996.tb00359.x","article-title":"A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases","volume":"15","author":"Joukov","year":"1996","journal-title":"Embo J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0845","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","article-title":"Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)","volume":"95","author":"Achen","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0850","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvs136","article-title":"Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases","volume":"153","author":"Shibuya","year":"2013","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0855","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1093\/emboj\/20.17.4762","article-title":"Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C\/D receptor VEGFR-3","volume":"20","author":"Makinen","year":"2001","journal-title":"Embo J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0860","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1152\/physiolgenomics.00037.2006","article-title":"Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro","volume":"28","author":"Wick","year":"2007","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0865","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9440(10)63851-5","article-title":"Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells","volume":"162","author":"Hirakawa","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0870","doi-asserted-by":"crossref","first-page":"16069","DOI":"10.1073\/pnas.242401399","article-title":"Molecular characterization of lymphatic endothelial cells","volume":"99","author":"Podgrabinska","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0875","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1084\/jem.194.6.797","article-title":"Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages","volume":"194","author":"Kriehuber","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0880","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10585-005-3973-5","article-title":"Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells","volume":"22","author":"Fukumoto","year":"2005","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0885","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053449","article-title":"Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0890","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1067\/mai.2001.113238","article-title":"Human skin mast cells adhere to vitronectin via the alphavbeta3 integrin receptor (CD51\/CD61)","volume":"107","author":"Columbo","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0895","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.4049\/jimmunol.154.11.6058","article-title":"Human skin mast cells express functional beta 1 integrins that mediate adhesion to extracellular matrix proteins","volume":"154","author":"Columbo","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0900","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0905","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1745-7254.2005.00009.x","article-title":"Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys","volume":"26","author":"Song","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0910","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1158\/1078-0432.CCR-07-1530","article-title":"Sjin, S. Movahedi, B. Ahmed, E.A. Pravda, K.M. Lo, S.D. Gillies, J. Folkman, K. Javaherian, Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy","volume":"14","author":"Lee","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0915","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1172\/JCI1558","article-title":"Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases","volume":"101","author":"Cao","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0920","first-page":"5575","article-title":"A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis","volume":"61","author":"Guba","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0925","doi-asserted-by":"crossref","first-page":"H428","DOI":"10.1152\/ajpheart.00283.2008","article-title":"Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation","volume":"296","author":"Sodha","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0930","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0002-9149(84)90388-6","article-title":"Functional importance of coronary collateral vessels","volume":"53","author":"Goldberg","year":"1984","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0935","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJM197106102842301","article-title":"Functional importance of the human coronary collateral circulation","volume":"284","author":"Helfant","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0940","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0002-8703(89)90771-0","article-title":"Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion","volume":"117","author":"Hansen","year":"1989","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0945","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/01.CIR.83.3.739","article-title":"Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators","volume":"83","author":"Habib","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.bbagen.2015.09.007_bb0950","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/emboj\/19.6.1187","article-title":"Secreted cathepsin L generates endostatin from collagen XVIII","volume":"19","author":"Felbor","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0955","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1749-6632.1997.tb48462.x","article-title":"Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease","volume":"826","author":"de la Torre","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0960","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.1997.tb48461.x","article-title":"Cerebrovascular hypoperfusion: a risk factor for Alzheimer's disease? Animal model and postmortem human studies","volume":"826","author":"De Jong","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0965","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MNH.0b013e32831ec1db","article-title":"Angiogenesis in the kidney: a new therapeutic target?","volume":"18","author":"Lerman","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0970","doi-asserted-by":"crossref","first-page":"F717","DOI":"10.1152\/ajprenal.00071.2008","article-title":"Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition","volume":"295","author":"Stoessel","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0975","doi-asserted-by":"crossref","first-page":"H285","DOI":"10.1152\/ajpheart.00560.2006","article-title":"Chronic NOS inhibition actuates endothelial-mesenchymal transformation","volume":"292","author":"O'Riordan","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0980","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000336109","article-title":"Elevated plasma levels of endostatin are associated with chronic kidney disease","volume":"35","author":"Chen","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0985","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/modpathol.3800336","article-title":"Increased endostatin\/collagen XVIII expression correlates with elevated VEGF level and poor prognosis in hepatocellular carcinoma","volume":"18","author":"Hu","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0990","first-page":"45","article-title":"Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas","volume":"61","author":"Musso","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb0995","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/jhep.2001.23189","article-title":"Tumor hepatocytes and basement membrane-Producing cells specifically express two different forms of the endostatin precursor, collagen XVIII, in human liver cancers","volume":"33","author":"Musso","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1000","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/030089161209800614","article-title":"Clinical value of vascular endothelial growth factor and endostatin in urine for diagnosis of bladder cancer","volume":"98","author":"Cheng","year":"2012","journal-title":"Tumori"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s13277-010-0122-9","article-title":"Suppression of bladder cancer growth in mice by adeno-associated virus vector-mediated endostatin expression","volume":"32","author":"Pan","year":"2011","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1010","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1097\/01.ju.0000091879.18156.22","article-title":"The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism","volume":"170","author":"Du","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1015","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/ijc.26343","article-title":"Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer","volume":"130","author":"Szarvas","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1020","first-page":"2651","article-title":"Prognostic significance of the angiogenic factors angiogenin, endoglin and endostatin in cervical cancer","volume":"31","author":"Landt","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1025","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7314\/APJCP.2012.13.3.923","article-title":"Early efficacy of Endostar combined with chemoradiotherapy for advanced cervical cancers","volume":"13","author":"Ke","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1030","first-page":"316","article-title":"Recombinant human endostatin, Endostar, enhances the effects of chemo-radiotherapy in a mouse cervical cancer xenograft model","volume":"32","author":"Jia","year":"2011","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1035","first-page":"3087","article-title":"Clinical observation of Endostar(R) combined with chemotherapy in advanced colorectal cancer patients","volume":"12","author":"Xu","year":"2011","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1040","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/bjc.2014.456","article-title":"Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers","volume":"111","author":"Kantola","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1045","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.18632\/oncotarget.3121","article-title":"Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1050","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00280-014-2656-9","article-title":"Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trial","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1055","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clon.2012.11.009","article-title":"Elevated serum endostatin levels are associated with poor survival in patients with advanced-stage nasopharyngeal carcinoma","volume":"25","author":"Mo","year":"2013","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1060","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/mt.2014.53","article-title":"Multicenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinoma","volume":"22","author":"Ye","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/cgt.2011.72","article-title":"Mc-hES, a novel plasmid carrying human endostatin gene, inhibits nasopharyngeal carcinoma growth","volume":"19","author":"Xu","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201409-1742OC","article-title":"Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension","volume":"191","author":"Damico","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1075","unstructured":"J. Golledge, P. Clancy, Serum endostatin concentrations are higher in men with symptoms of intermittent claudication, 2014 (2014) 298239."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1080","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3233\/JAD-142544","article-title":"Endostatin level in cerebrospinal fluid of patients with Alzheimer's disease","volume":"44","author":"Salza","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1155\/2013\/402375","article-title":"Endostatin\/collagen XVIII is increased in cerebrospinal fluid after severe traumatic brain injury","volume":"2013","author":"Chen","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.expneurol.2007.07.020","article-title":"Lesional expression of the endogenous angiogenesis inhibitor endostatin\/collagen XVIII following traumatic brain injury (TBI)","volume":"208","author":"Mueller","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/tropej\/fmq112","article-title":"Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants","volume":"57","author":"Mohamed","year":"2011","journal-title":"J. Trop. Pediatr."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1100","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1542\/peds.2008-1339","article-title":"Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants","volume":"123","author":"Janer","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1105","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.4049\/jimmunol.1103216","article-title":"Immunological disruption of antiangiogenic signals by recruited allospecific T cells leads to corneal allograft rejection","volume":"188","author":"Tan","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2013.10.068","article-title":"Anti-proliferative effect of recombinant human endostatin on synovial fibroblasts in rats with adjuvant arthritis","volume":"723","author":"Huang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1115","first-page":"2339","article-title":"Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis","volume":"27","author":"Nagashima","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1120","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1167\/iovs.02-0374","article-title":"Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin","volume":"44","author":"Funatsu","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1995-7645(12)60032-7","article-title":"Evaluation of serum and pleural levels of endostatin and vascular epithelial growth factor in lung cancer patients with pleural effusion","volume":"5","author":"Zhang","year":"2012","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1130","first-page":"381","article-title":"Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions","volume":"13","author":"Zhou","year":"2009","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2613.2002.00240.x","article-title":"Delivery of endostatin in experimental cancer therapy","volume":"83","author":"Sorensen","year":"2002","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1150","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1096\/fj.04-2134rev","article-title":"Physiological role of collagen XVIII and endostatin","volume":"19","author":"Marneros","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1155","doi-asserted-by":"crossref","unstructured":"R. Xu, N. Ma, F. Wang, L. Ma, R. Chen, R. Chen, M. Kebinu, L. Ma, Z. Han, Ayixiamu, M. Mayier, P. Su, Y. Naman, H. Jieensi, H. Yang, A. Adili, S. Aili, J. Liu, Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer, Oncol. Targets Ther., 6 (2013) 925\u2013929.","DOI":"10.2147\/OTT.S46487"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1160","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/mt.2013.79","article-title":"A phase II, randomized, double-blind, placebo-controlled multicenter trial of endostar in patients with metastatic melanoma","volume":"21","author":"Cui","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1165","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1477-7819-10-170","article-title":"Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer","volume":"10","author":"Rong","year":"2012","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1170","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1471-2407-13-248","article-title":"Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study","volume":"13","author":"Chen","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1175","article-title":"E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases","author":"Zhao","year":"2008","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1180","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2203\/dose-response.10-020.Javaherian","article-title":"Two endogenous antiangiogenic inhibitors, endostatin and angiostatin, demonstrate biphasic curves in their antitumor profiles","volume":"9","author":"Javaherian","year":"2011","journal-title":"Dose Response"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1185","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.4161\/cbt.3.11.1219","article-title":"Opposite effects of endostatin on different endothelial cells","volume":"3","author":"Schmidt","year":"2004","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1190","doi-asserted-by":"crossref","DOI":"10.2337\/db14-0528","article-title":"Endostatin prevents dietary-induced obesity by inhibiting adipogenesis and angiogenesis","author":"Wang","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.exppara.2011.01.016","article-title":"Evaluation of the role of angiogenic factors in the pathogenesis of schistosomiasis","volume":"128","author":"Shariati","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/TP.0b013e3181636d9d","article-title":"Effect of CXCL-1\/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection","volume":"85","author":"Amescua","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/08830180212064","article-title":"Immunology and immunomodulation of corneal transplantation","volume":"21","author":"Niederkorn","year":"2002","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1215","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/01.tp.0000203140.70742.cb","article-title":"CD4+ T-cell-independent rejection of corneal allografts","volume":"81","author":"Niederkorn","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1220","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1177\/030006051204000522","article-title":"Endostatin gene therapy for endometriosis in rats","volume":"40","author":"Zhang","year":"2012","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1225","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canlet.2015.01.012","article-title":"Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis","volume":"359","author":"Xiao","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1230","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00424-013-1427-5","article-title":"Low-voltage-activated T-type Ca2+ channel inhibitors as new tools in the treatment of glioblastoma: the role of endostatin","volume":"466","author":"Zhang","year":"2014","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1235","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2177\/jsci.36.452","article-title":"Role of endostatin in fibroproliferative disorders\u2014as a candidate for anti-fibrosis therapy","volume":"36","author":"Yamaguchi","year":"2013","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1240","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pan.2013.05.012","article-title":"Experimental studies on treatment of pancreatic cancer with double-regulated duplicative adenovirus AdTPHre-hEndo carrying human endostatin gene","volume":"13","author":"Shan","year":"2013","journal-title":"Pancreatology"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1245","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/abbs\/gmt070","article-title":"Antitumor effects of Endostar on non-Hodgkin's lymphoma by regulating endothelial progenitor cells through protein kinase B-dependent pathway","volume":"45","author":"Yu","year":"2013","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1250","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3892\/ijmm.2012.1197","article-title":"Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model","volume":"31","author":"Wang","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1255","doi-asserted-by":"crossref","first-page":"11306","DOI":"10.1073\/pnas.1203275109","article-title":"Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition","volume":"109","author":"Sunshine","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1260","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biopha.2011.11.002","article-title":"Endostatin neoadjuvant gene therapy extends survival in an orthotopic metastatic mouse model of renal cell carcinoma","volume":"66","author":"de Souza Braga","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1265","first-page":"7669","article-title":"Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model","volume":"61","author":"Kisker","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1270","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/bc050355d","article-title":"Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin","volume":"17","author":"Nie","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1275","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00063030-200822050-00004","article-title":"The impact of PEGylation on biological therapies","volume":"22","author":"Veronese","year":"2008","journal-title":"BioDrugs"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1280","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ijc.20336","article-title":"Addition of integrin binding sequence to a mutant human endostatin improves inhibition of tumor growth","volume":"111","author":"Yokoyama","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1285","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/CAD.0b013e328342050d","article-title":"A tumor-penetrating peptide modification enhances the antitumor activity of endostatin in vivo","volume":"22","author":"Hai-Tao","year":"2011","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1290","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pep.2013.10.005","article-title":"Zinc supplementation protects human endostatin Fc fusion against proteolytic degradation during cell culture","volume":"93","author":"Hao","year":"2014","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1295","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2147\/IJN.S14753","article-title":"Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation","volume":"5","author":"Hu","year":"2010","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1300","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/sj.cgt.7700396","article-title":"Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo","volume":"8","author":"Jin","year":"2001","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1305","first-page":"1809","article-title":"Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein","volume":"117","author":"Liang","year":"2004","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1310","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1073\/pnas.090065597","article-title":"Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases","volume":"97","author":"Sauter","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1315","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.cgt.7700388","article-title":"Development of lentiviral vectors for antiangiogenic gene delivery","volume":"8","author":"Shichinohe","year":"2001","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1320","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/jnci\/93.13.1014","article-title":"Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of murine tumors","volume":"93","author":"Feldman","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1325","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/sj.cgt.7700367","article-title":"Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus","volume":"8","author":"Yamanaka","year":"2001","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1330","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/jgm.626","article-title":"Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models","volume":"6","author":"Lee","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1335","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/7895","article-title":"Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene","volume":"17","author":"Blezinger","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1340","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ymthe.2004.10.008","article-title":"Endostatin cDNA\/cationic liposome complexes as a promising therapy to prevent lung metastases in osteosarcoma: study in a human-like rat orthotopic tumor","volume":"11","author":"Dutour","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1345","first-page":"3308","article-title":"Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice","volume":"59","author":"Chen","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.09.007_bb1350","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2014\/298239","article-title":"Serum endostatin concentrations are higher in men with symptoms of intermittent claudication","volume":"2014","author":"Golledge","year":"2014","journal-title":"Dis. Markers"},{"key":"10.1016\/j.bbagen.2015.09.007_bb1355","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12032-011-9972-2","article-title":"Clinical significance of vascular endothelial growth factor and endostatin levels in the differential diagnosis of malignant and benign ascites","volume":"29","author":"Cheng","year":"2012","journal-title":"Med. Oncol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416515002391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416515002391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T01:30:12Z","timestamp":1691976612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416515002391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":271,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0304416515002391"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2015.09.007","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2015.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}